Radon-induced lung cancer in French and Czech miner cohorts described with a two-mutation cancer model

. 2004 Sep ; 43 (3) : 153-63. [epub] 20040817

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu srovnávací studie, hodnotící studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid15316819

A two-mutation carcinogenesis model with clonal expansion of pre-malignant cells is used to describe lung cancer mortality data from studies on French and Czech miners with relatively low exposures to radon. The aim was to derive radon-induced lung cancer risk estimates applicable to different populations using a model description consistent with both cellular dose-response relationships, and previous model analyses of animal and human epidemiological data. The significantly different baseline lung cancer risks for the two cohorts that include the effects from the unknown smoking habits, are described with different background model parameters. A uniform description of the effect of radon for both miner cohorts is achieved by applying the same multiplicative effect for radon on the background mutation rates in the model. Incorporating the effects of decreased cellular proliferation at very advanced age improves the description of the baseline lung cancer risk, but does not lead to significant changes in the estimated radiation parameters. Here, a multi-stage model demonstrates the possibility of transferring radon-induced lung cancer risks across populations. The inherent age-time dose-rate relationships in the model allow for extrapolation to lifelong exposures to residential radon concentrations. The resulting cumulated (lifetime) risks from continuous exposure to low-level radon concentrations were found to agree with the results of the BEIR VI models.

Komentář v

PubMed

Zobrazit více v PubMed

Radiat Res. 1999 Dec;152(6 Suppl):S59-63 PubMed

Health Phys. 1992 Sep;63(3):259-72 PubMed

Mutat Res. 2000 Jan 17;447(1):73-116 PubMed

Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 PubMed

Radiat Prot Dosimetry. 2003;104(4):321-9 PubMed

Radiat Prot Dosimetry. 2003;104(4):315-9 PubMed

Radiat Res. 2002 Nov;158(5):597-606 PubMed

Int J Radiat Biol. 2002 Jan;78(1):49-68 PubMed

Radiat Res. 1996 Feb;145(2):163-73 PubMed

Radiat Environ Biophys. 2001 Mar;40(1):11-21 PubMed

Radiat Environ Biophys. 2000 Dec;39(4):253-64 PubMed

J Natl Cancer Inst. 1997 Jan 1;89(1):49-57 PubMed

J Radiol Prot. 2002 Sep;22(3A):A107-12 PubMed

Eur J Epidemiol. 2004;19(2):139-46 PubMed

J Radiol Prot. 2000 Jun;20(2):169-88 PubMed

J Radiol Prot. 2002 Sep;22(3A):A75-9 PubMed

Radiat Environ Biophys. 1999 May;38(1):57-71 PubMed

Risk Anal. 1988 Sep;8(3):383-92 PubMed

Health Phys. 1995 Oct;69(4):494-500 PubMed

Health Phys. 2002 Jul;83(1):1-18 PubMed

J Radiol Prot. 2002 Sep;22(3A):A101-6 PubMed

Risk Anal. 1990 Jun;10(2):323-41 PubMed

Mutat Res. 1996 Sep 23;356(2):209-16 PubMed

Radiat Prot Dosimetry. 2002;99(1-4):265-8 PubMed

Radiat Environ Biophys. 2001 Dec;40(4):269-77 PubMed

Radiat Res. 2001 Nov;156(5 Pt 2):662-7 PubMed

Radiat Res. 1999 Oct;152(4):339-51 PubMed

Radiat Res. 2001 Jul;156(1):78-94 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...